Systimmune’s iza-bren hits phase III breast cancer goals in China
Systimmune’s iza-bren hits phase III breast cancer goals in China
Systimmune’s iza-bren hits phase III breast cancer goals in China
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.